investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Harnessing beneficial off-target effects of kinase inhibitors in lung cancer
Uwe Rix
4 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
John Koomen
University of South Florida
Tampa, United States
Eric Haura
University of South Florida
Tampa, United States
Steven Eschrich
University of South Florida
Tampa, United States
Uwe Rix
Moffitt Cancer Center
Tampa, United States
University of South Florida
Tampa, United States
Thomas Metz
Oncotest GmbH
Freiburg, Germany
Related projects
Alexander D Sorkin
Pathogenesis of Cancer: Role of EGF Receptor Endocytosis
Trachea, bronchus and lung
Pathology
Allan Balmain
The Role of the Kras4A Isoform in Epithelial Carcinogenesis
Trachea, bronchus and lung
Pathology
Jeffrey Schlom
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
Trachea, bronchus and lung
Pathology
Brid Ryan
Examining the Inverse Relationship Between Parkinson's Disease and Lung Cancer
Trachea, bronchus and lung
Pathology
Elisabeth D Martinez
Characterization of the biological activities of novel epigenetic modulators
Trachea, bronchus and lung
Pathology
Joseph R Testa
RIP1/3 Kinases as New Targets in Malignant Mesothelioma
Trachea, bronchus and lung
Pathology
Pasi A Janne
Targeting RET in Lung Cancer
Trachea, bronchus and lung
Pathology
Elsa Flores
Drug Repositioning for Pharmacological Manipulation of p53 Family Members in p53 Mutant and Deficient Lung Tumors
Trachea, bronchus and lung
Pathology
Jennifer Brady
Mechanisms governing tumor differentiation and metastasis
Trachea, bronchus and lung
Pathology
